What does Preamble of S 2842 do?

This bill aims to amend the Public Health Service Act. The proposed amendment concerns congenital Cytomegalovirus (CMV) screening of newborns.

What does SHORT TITLE. of S 2842 do?

This bill is formally titled Stop CMV Act of 2025.

What does SCREENING OF CONGENITAL CYTOMEGALOVIRUS. of S 2842 do?

This section amends the Public Health Service Act to establish screening for congenital Cytomegalovirus (CMV) in infants up to 21 days of age. States may prescribe standards and procedures for administering CMV tests, recording results, tracking activities, conducting follow-up reviews, and disseminating information to parents or guardians. If a State fails to prescribe approved standards and procedures within two years of the Stop CMV Act of 2025's enactment, the Discretionary Advisory Committee on Heritable Disorders in Newborns and Children will prescribe them. The Health Resources and Services Administration (HRSA) is authorized to award grants to States for administering CMV tests. The Centers for Disease Control and Prevention (CDC) is authorized to award grants to States for technical assistance related to data collection and education regarding CMV. The National Institutes of Health (NIH) is authorized to establish or expand research and development programs related to CMV screening techniques, diagnostics, prevention, treatment, and vaccine development.

What does ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND of S 2842 do?

This section amends Section 1111(b) of the Public Health Service Act. Paragraph (7) of Section 1111(b) is modified by removing the word 'and' after the semicolon. Paragraph (8) of Section 1111(b) is redesignated as paragraph (9). A new paragraph (8) is inserted after paragraph (7) to authorize activities under section 1116A.

Back to bills

Stop CMV Act of 2025 — S. 2842

Last updated: 9/17/2025 · Introduced: 9/17/2025

Author: Richard Blumenthal (D-CT)

TL;DR (AI)

This bill mandates congenital Cytomegalovirus (CMV) screening for all infants up to 21 days of age.
It authorizes grants from HRSA to states for administering CMV tests and from the CDC for technical assistance and education.
The bill supports research and development programs at the National Institutes of Health (NIH) related to CMV screening, diagnostics, prevention, treatment, and vaccine development.

119th Congressin committeeHR. 5435(In Committee)Official page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 2 more.

4 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account